<VariationArchive RecordType="classified" VariationID="29949" VariationName="NM_001379110.1(SLC9A6):c.856_864del (p.Gly286_Ala288del)" VariationType="Deletion" Accession="VCV000029949" Version="3" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2021-08-24" MostRecentSubmission="2021-08-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="38904" VariationID="29949">
      <GeneList>
        <Gene Symbol="SLC9A6" FullName="solute carrier family 9 member A6" GeneID="10479" HGNC_ID="HGNC:11079" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq26.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="135973837" stop="136047269" display_start="135973837" display_stop="136047269" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="135067582" stop="135129427" display_start="135067582" display_stop="135129427" Strand="+" />
          </Location>
          <OMIM>300231</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC9A6">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC9A6">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001379110.1(SLC9A6):c.856_864del (p.Gly286_Ala288del)</Name>
      <CanonicalSPDI>NC_000023.11:136010553:GGTGCTGCT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq26.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="136010554" stop="136010562" display_start="136010554" display_stop="136010562" variantLength="9" positionVCF="136010553" referenceAlleleVCF="GGGTGCTGCT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="135092713" stop="135092721" display_start="135092713" display_stop="135092721" variantLength="9" positionVCF="135092712" referenceAlleleVCF="GGGTGCTGCT" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.135092713_135092721del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.135092713_135092721del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.136010554_136010562del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.136010554_136010562del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_017160.1" sequenceAccession="NG_017160" sequenceVersion="1" change="g.30128_30136del">
            <Expression>NG_017160.1:g.30128_30136del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042537.2" sequenceAccession="NM_001042537" sequenceVersion="2" change="c.1012_1020del">
            <Expression>NM_001042537.2:c.1012_1020del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001036002.1" sequenceAccession="NP_001036002" sequenceVersion="1" change="p.Gly338_Ala340del">
            <Expression>NP_001036002.1:p.Gly338_Ala340del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001177651.2" sequenceAccession="NM_001177651" sequenceVersion="2" change="c.856_864del">
            <Expression>NM_001177651.2:c.856_864del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001171122.1" sequenceAccession="NP_001171122" sequenceVersion="1" change="p.Gly286_Ala288del">
            <Expression>NP_001171122.1:p.Gly286_Ala288del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330652.2" sequenceAccession="NM_001330652" sequenceVersion="2" change="c.760_768del">
            <Expression>NM_001330652.2:c.760_768del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317581.1" sequenceAccession="NP_001317581" sequenceVersion="1" change="p.Gly254_Ala256del">
            <Expression>NP_001317581.1:p.Gly254_Ala256del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001379110.1" sequenceAccession="NM_001379110" sequenceVersion="1" change="c.856_864del" MANESelect="true">
            <Expression>NM_001379110.1:c.856_864del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001366039.1" sequenceAccession="NP_001366039" sequenceVersion="1" change="p.Gly286_Ala288del">
            <Expression>NP_001366039.1:p.Gly286_Ala288del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006359.3" sequenceAccession="NM_006359" sequenceVersion="3" change="c.916_924del">
            <Expression>NM_006359.3:c.916_924del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006350.1" sequenceAccession="NP_006350" sequenceVersion="1" change="p.Gly306_Ala308del">
            <Expression>NP_006350.1:p.Gly306_Ala308del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA128786" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300231.0005" DB="OMIM" />
        <XRef Type="rs" ID="398122849" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001379110.1(SLC9A6):c.856_864del (p.Gly286_Ala288del) AND Christianson syndrome" Accession="RCV000022841" Version="24">
        <ClassifiedConditionList TraitSetID="3135">
          <ClassifiedCondition DB="MedGen" ID="C2678194">Christianson syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2010-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2010-05-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-08-24" MostRecentSubmission="2021-08-24">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20395263</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3135" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5500" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE</ElementValue>
                <XRef Type="MIM" ID="300243" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Christianson syndrome</ElementValue>
                <XRef ID="306361" DB="GeneTests" />
                <XRef ID="Christianson+Syndrome/1400" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010278" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MRXS Christianson</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Angelman-like syndrome X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation microcephaly epilepsy and ataxia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked mental retardation, syndromic, Christianson type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SLC9A6-Related Syndromic Mental Retardation</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRXSCH</ElementValue>
                <XRef Type="MIM" ID="300243" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10572" />
                <XRef ID="10572" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Christianson syndrome (referred to as CS in this GeneReview), an X-linked disorder, is characterized in males by cognitive dysfunction, behavioral disorder, and neurologic findings (e.g., seizures, ataxia, postnatal microcephaly, and eye movement abnormalities). Males with CS typically present with developmental delay, later meeting criteria for severe intellectual disability (ID). Behaviorally, autism spectrum disorder and hyperactivity are common, and may resemble the behaviors observed in Angelman syndrome. Hypotonia and oropharyngeal dysphagia in infancy may result in failure to thrive. Seizures, typically beginning before age three years, can include infantile spasms and tonic, tonic-clonic, myoclonic, and atonic seizures. Subsequently, regression (e.g., loss of ambulation and ability to feed independently) may occur. Manifestations in heterozygous females range from asymptomatic to mild ID and/or behavioral issues.</Attribute>
                <XRef ID="NBK475801" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29334451</ID>
                <ID Source="BookShelf">NBK475801</ID>
              </Citation>
              <XRef ID="85278" DB="Orphanet" />
              <XRef ID="C2678194" DB="MedGen" />
              <XRef ID="MONDO:0010278" DB="MONDO" />
              <XRef Type="MIM" ID="300243" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="49386" SubmissionDate="2021-08-20" DateLastUpdated="2021-08-24" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300231.0005_INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE" title="SLC9A6, 9-BP DEL, NT1012_INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE" />
        <ClinVarAccession Accession="SCV000044130" DateUpdated="2021-08-24" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a family with the Christianson type of X-linked syndromic intellectual developmental disorder (MRXSCH; 300243), Garbern et al. (2010) identified a 9-bp deletion (1012_1020del) in exon 8 of the SLC9A6 gene, resulting in an in-frame deletion of 3 amino acids (338_340) in a conserved domain adjacent to a potential transmembrane domain. The phenotype included profoundly impaired intellectual development, autistic features, incontinence, and late-onset truncal ataxia. Variable features included small head, mutism, seizures, ophthalmoplegia, and hand-wringing. Dysmorphic features were not noted. Neuropathologic findings of 2 affected adult brothers showed generalized symmetric cerebral atrophy with atrophy of the white matter, and marked neuronal loss and gliosis of the globus pallidus, putamen, substantia nigra, and cerebellar cortex. There were numerous tau (MAPT; 157140)-positive intracellular inclusions in the glial cells throughout the white matter and strongly tau-positive tangle-like inclusions in neurons of the substantia nigra, locus ceruleus, pontine nuclei, basal ganglia, thalami, and cranial nerve nuclei. Tau-positive neurons were also found in the cerebral cortex and hippocampus. The tau proteins were predominantly of the 4R type, were insoluble, and highly phosphorylated. The neuropathologic findings resembled those seen in tauopathies caused by MAPT mutations (600274), but no MAPT mutations were found in this family. Garbern et al. (2010) suggested that the pathogenesis of this disorder resulted from aberrant MAPT processing, suggesting a possible interaction between the SLC9A6 function and cytoskeletal elements involved in vesicular transport.</Attribute>
              <Citation>
                <ID Source="PubMed">20395263</ID>
              </Citation>
              <XRef DB="OMIM" ID="300243" Type="MIM" />
              <XRef DB="OMIM" ID="157140" Type="MIM" />
              <XRef DB="OMIM" ID="600274" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC9A6" />
          </GeneList>
          <Name>SLC9A6, 9-BP DEL, NT1012</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">9-BP DEL, NT1012</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300231.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="49386" TraitType="Disease" MappingType="Name" MappingValue="INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE" MappingRef="Preferred">
        <MedGen CUI="C2678194" Name="Christianson syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

